Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
4-hydroxy-2-methyl-13C,D3-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90 %
Hazard Compound
No -Refer MSDS for accurate information
Meloxicam-13C,d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Meloxicam-13C,d3 usage and description
Meloxicam 13CD3 is a deuterated analogue of the nonsteroidal anti-inflammatory drug (NSAID) Meloxicam. It is used as a pain reliever, to reduce inflammation, and to treat symptoms of osteoarthritis and rheumatoid arthritis. Meloxicam 13CD3 works by inhibiting the production of prostaglandins, which are responsible for inflammation and pain in the body.
The deuterium substitution in Meloxicam 13CD3 enhances its stability, making it more resistant to metabolic breakdown in the body. This results in a longer half-life and improved pharmacokinetic properties compared to the non-deuterated form of Meloxicam. It also has a higher affinity for the COX-2 enzyme, which is responsible for inflammation and pain.
Meloxicam 13CD3 is available as an oral tablet, and the recommended dose varies depending on the condition being treated and the patient's medical history. It is important to follow the prescribed dosage and to avoid taking more than recommended, as it can increase the risk of side effects such as gastrointestinal bleeding or kidney damage. It should also not be taken by individuals with a history of allergic reactions to NSAIDs or aspirin.
Overall, Meloxicam 13CD3 is a useful medication for managing pain and inflammation associated with arthritis and other conditions. Its enhanced stability and affinity for the COX-2 enzyme make it a promising option for patients who require long-term pain management.
